Cellular sensitization in normal subjects and in patients with malignant disease Percentage Frequency mobility reduction ( 12 5 % were all laboratory workers who had been exposed to nervous tissue antigens and Freund's adjuvant, which may account for their increased sensitization. The patients in the overlap area were suffering from advanced metastatic carcinoma and were known to have depressed delayed hypersensitivity responses which may have affected their cellular responses in the same way. One patient, referred as suffering from malaise, weight loss and general chronic illness, gave a completely negative result; his illness was finally diagnosed as aleukemic leukxemia. There appears to be no definite correlation between either the extent or the site of malignancy and the amount of cellular sensitization. It is still difficult to make an absolute diagnosis by this test in patients with neurological disease, sarcoidosis, disseminated lupus erythematosus and possibly active tuberculosis or rheumatoid arthritis. The differences are perhaps statistically significant in the first group if brain secondaries can be definitely excluded, but in the others arising from a general loss of immune discrimination or immunization with a very similar antigen, results must remain suggestive rather than certain. Benign tumours and chronic conditions have so far given negative results. In 7 cases giving a positive result the clinical diagnosis of malignancy remains in doubt; a further 3 cases were suffering from 'semi-malignant' conditions (plexiform neurofibroma, &c.).
The lymphocyte sensitization test can be applied to all cases of malignant neoplasia except the leukeemias, but not for the detection of recurrence or metastases. The cells, once sensitized, remain so for many years (Field & Caspary 1970) . Routine use of this technique presents considerable difficulty and precludes its applica, tion to screening; it is best applied in doubtful cases to detect a malignant process, but is regrettably not capable of localizing the lesion. Addendum (April 1972): One case with a doubtful diagnosis of malignancy has since been admitted with cancer of the large bowel. Increasing interest is being shown in the possibilities of using immunologically based procedures for the diagnosis and treatment of malignant disease. This communication describes a two-year, double-blind, controlled trial of an intradermal tumour test carried out on a series of 340 patients presenting with signs or symptoms suggesting the presence of a tumour.
The test employed developed from the work of Makari, who reported on the presence in carcinomatous patients of carcinoma-specific antigens (Makari 1955) and later extended his observations to both malignant and benign tumours (Makari 1958b ). These antigens have been shown to be polysaccharide or glycoprotein in nature (Makari 1958a; Smith 1963, unpublished communication to USA Food and Drug Administration; Jeanloz 1970, personal communication to Dr J Goddard).
Makari originally used the highly sensitive Schultz-Dale technique using desensitization procedures to eliminate the interfering effects of normal antigens. However, technical difficulties severely restricted its potential as procedure for general use. An intradermal test procedure was, therefore, developed (Makari 1960 (Makari , 1962 . This was based on the injection into the skin of polysaccharide-containing fractions (referred to as tumour polysaccharidal substances or TPS) extracted from carcinomas, sarcomas and lymphomas, that were complexed with antibodies * Comparisons were not made where the number ofcases was less than 6 * Highly significantP< 0-005 present in the patient's serum, with which the antigens had previously been incubated. The diameters of the resulting erythema were measured and compared to those of appropriate serum controls in the same patient. It was found that a ratio of 1-35 or greater gave a close correlation with the presence of early neoplastic disease, and ratios of or above this value were considered to constitute a positive reaction. In this study the antigens (TPS) were prepared by subjecting extracts from lung carcinoma, sarcoma and lymphoma to degradative chemical and physical separative procedures (Makari 1958a ). An extract of normal lung tissue (NPS) was employed as one control, together with others consisting of isotonic saline and untreated or trypsin-treated serum, both alone and complexed with NPS.
The test preparations were prepared aseptically; 0 1 ml diluted serum was pipetted into each of ten sterile tubes labelled 1-10, 01 ml isotonic saline was added to each of Tubes 1, 2, 3, 4, 9 and 11, and 0 1 ml of the trypsin working solution (0-02 mg/ml) was added to each of Tubes 5, 6, 7, 8 and 10. The rack was shaken gently and left at 5oC for 30 min. Then 0-1 ml sterile isotonic saline was added to Tubes 1 and 5, 0-1 ml TPS-1 to Tubes 2 and 6, 0 1 ml TPS-2 to Tubes 3 and 7, 0-1 ml TPS-3 to Tubes 4 and 8 and 0 1 ml NPS to Tubes 9 and 10. The rack was shaken gently and placed in the refrigerator for 24 hours.
After 24 hours refrigeration 01 ml aliquots were injected into the patient's skin on either side of the spinal column starting 3 in. (76 mm) below the prominence of the 7th cervical vertebra. Six injections were made on the left and five on the right. After an interval of 2 min from the first injection the longest diameter of the erythema and the diameter at right angles were measured at each injection site sequentially.
The study was carried out on a double-blind controlled basis. The syringes were coded by an assistant according to a table ofrandom numbers. Thus the physician administering the injections knew neither which material had been injected into any site, nor the patient's diagnosis. Also, in most cases the test was carried out before a definitive diagnosis had been made, usually before surgery.
The patients subjected to the test were selected from inpatients and outpatients attending King's College Hospital, with the object of studying the behaviour of the test with a wide variety of patients, tumour sites and types of disease and conditions other than neoplastic.
The definitive diagnosis of carcinoma or other type of tumour was arrived at only after histological examination of the tumours. If no definitive histological categorization could be made the patient was assigned to the 'questionable tumour' group.
Since the positivity rate exhibited by this procedure falls off with increasing stage of tumour advancement, the tumours were classified into four stages: (1) tumour less than 2 cm diameter or the mucosa only involved; (2) tumour between 2 and 3 cm diameter or muscularis mucosa involved; (3) tumour greater than
Results and Discussion
Of the 340 patients studied, the results of which are summarized in Table 1 , 25 were found to be suffering from early or Stage 1 and 2 carcinoma, and 97 from more advanced or Stage 3 and 4 carcinoma. Of the Stage 1 and 2 patients positive results were seen in 85-7 % and 61 % respectively. These, when compared to the 21-3% positive results in the 61 patients with non-neoplastic disease, are highly significant (P< 0-005).
The results showed fall-off in percentage positive tests in more advanced states of the disease: 85-7 %, 61 %, 10% and 22-4% in Stages 1, 2, 3 and 4 respectively. This may be attributed to the phenomenon of immunoparalys.is which appears to develop with gross spread of the tumour (Makari 1969) .
It is of interest in relation to the report of the Committee on Cancer Detection of the International Union against Cancer (Phillips et al. 1969 ) that the present study exemplifies the advantage of the immunological compared to the cytological type of cancer detection test. The latter, of course, depends upon having access to the organ thought to be involved, whereas the former does not. Thus in the Stage 1 and 2 patients positive results were seen on testing patients subsequently found to have carcinoma of the breast, ovary, bladder, prostate, larynx, colon and rectum.
On the other hand, however, a positive test should also direct attention to the exclusion of the presence of the other conditions which have so far been shown to have relatively high response rates. These are peptic ulcer, diverticulitis, ulcerative colitis and fibrocystic disease of the breast.
The present findings are generally similar to those of studies carried out in the United States (Makari 1969) , Japan (Honda et al. 1972) and France (Boisivon 1972) . Including the present study, reports are now available on the results of testing in over 1,500 patients. Much work obviously remains to be carried out, but the preliminary impression must be that this test, which is now shown to involve a valid phenomenon as judged by statistical tests of significance, is likely to prove of value as a diagnostic test in patients thought to have early carcinoma.
